Chuo-ku, Japan

Ayatoshi Ando



Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Chuo-ku, JP (2020)
  • Kawasaki, JP (2017 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ayatoshi Ando: Innovator in Therapeutic Agents

Introduction

Ayatoshi Ando, based in Chuo-ku, Japan, is a distinguished inventor known for his contributions to the field of therapeutic agents. With three patents to his name, his work primarily focuses on novel solutions for treating complex health conditions.

Latest Patents

Among his latest innovations, Ando has developed a therapeutic agent specifically designed for fatty liver diseases. This invention aims to provide an effective treatment option through a compound represented by a specific formula. Additionally, he has created substituted benzenesulfonamides that act as inhibitors of alpha-4 beta-7 integrin activity. This compound demonstrates α4 integrin inhibitory action and offers promising therapeutic potential.

Career Highlights

Ayatoshi Ando is affiliated with Ea Pharma Co., Ltd., a company renowned for advancing pharmaceutical innovations. His work has significantly impacted the development of targeted therapies, making him a pivotal figure in the research community. His expertise and creative thinking have led to advancements in medical science that may improve patient outcomes.

Collaborations

Throughout his career, Ando has collaborated with notable colleagues, including Misato Noguchi and Yuki Saitou. Working alongside these talented individuals has allowed him to enhance his research and drive forward innovative solutions in the pharmaceutical industry.

Conclusion

Ayatoshi Ando exemplifies the spirit of innovation in therapeutic development. His patented inventions represent a significant step forward in treating fatty liver diseases and enhancing drug efficacy. As he continues to push the boundaries of science, his contributions will likely have lasting impacts in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…